Name | 4-amino-1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one |
---|---|
Synonyms |
valopicitabine
2-C-METHYLCYTIDINE 2'-C-Methyl Cytidine Cytidine,2'-C-methyl 2'-METHYLCYTIDINE NM107 Cytidine, 2'-C-methyl- UNII-27FS20C1D8 1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)-4-aminopyrimidin-2(1H)-one UNII:27FS20C1D8 2'-C-methylcytidine |
Description | NM107 is a inhibitors of HCV RNA replication with IC50 of 7.0 μM in vitro.IC50 value: 7.0 μMTarget:HCV RNA replicationNM107 is a potent and selective inhibitor of flavi- and pesti-virus replication in cell culture, with inhibitory activity and cytotoxicity against HCV 1b replicon cells, IC50 is 1.13 μM. Intracellular HCV RNA in HCV-infected cells treated the HCV polymerase inhibitor NM107 shows a similar pattern of decline. NM107 are currently being investigated as additional therapeutic agents for HCV infection. NM107 inhibits bovine viral diarrhea virus (BVDV) replication (EC50 0.67 nM), eliminates persistent BVDV infection at nontoxic concentrations. |
---|---|
Related Catalog | |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 523.9±60.0 °C at 760 mmHg |
Melting Point | 243-245ºC |
Molecular Formula | C10H15N3O5 |
Molecular Weight | 257.243 |
Flash Point | 270.7±32.9 °C |
Exact Mass | 257.101166 |
PSA | 130.83000 |
LogP | -0.80 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Index of Refraction | 1.700 |
Storage condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
Water Solubility | H2O: >20mg/mL |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36/37/38 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
HS Code | 2934999090 |
Precursor 9 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |